Using a large dataset (640k synthetic routes and 2.4m reactions) compiled from six popular journals between 2000 – 2020, trends are identified and discussed for topics including journal publishing rates, availability of machine-readable data, characteristics of synthetic route targets and starting materials (molecular weight, complexity, elemental composition, chirality and ring-systems) and the reaction classes utilised in these synthetic routes. We provide evidence of an ongoing shift away from large natural product or “total” syntheses amongst the academic data and a gradual increase in the size and complexity of industrial/medicinal target molecules. The reaction class analyses show key differences between the academic and industrial sectors and how a small number of reaction types have proliferated in the latter, giving rise to a possible lack of target diversity. Overall, there is evidence to support an ongoing increase in synthetic efficiency whereby, as a community, we are synthesizing larger, more-complex molecules from smaller, simpler starting materials, in fewer steps and with diminished reliance on non-productive reaction types such as protecting group manipulations, redox reactions and functional group interconversions.
No takes yet. Share an insight, caveat, or question.
Howell et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: